Virtu KCG Holdings LLC cut its stake in Chemed Corp. (NYSE:CHE) by 56.8% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,184 shares of the company’s stock after selling 2,866 shares during the period. Virtu KCG Holdings LLC’s holdings in Chemed Corp. were worth $447,000 at the end of the most recent quarter.
A number of other hedge funds also recently made changes to their positions in the stock. BlackRock Inc. boosted its holdings in shares of Chemed Corp. by 145,760.9% during the 1st quarter. BlackRock Inc. now owns 1,955,994 shares of the company’s stock worth $357,341,000 after buying an additional 1,954,653 shares in the last quarter. Vanguard Group Inc. boosted its holdings in shares of Chemed Corp. by 1.9% during the 2nd quarter. Vanguard Group Inc. now owns 1,830,711 shares of the company’s stock worth $374,435,000 after buying an additional 34,938 shares in the last quarter. Acadian Asset Management LLC boosted its holdings in shares of Chemed Corp. by 1.3% during the 2nd quarter. Acadian Asset Management LLC now owns 579,170 shares of the company’s stock worth $118,454,000 after buying an additional 7,636 shares in the last quarter. State Street Corp boosted its holdings in shares of Chemed Corp. by 9.1% during the 1st quarter. State Street Corp now owns 445,367 shares of the company’s stock worth $81,370,000 after buying an additional 37,085 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its holdings in shares of Chemed Corp. by 0.4% during the 1st quarter. Dimensional Fund Advisors LP now owns 393,983 shares of the company’s stock worth $71,979,000 after buying an additional 1,695 shares in the last quarter. Institutional investors and hedge funds own 96.96% of the company’s stock.
In other news, insider Kevin J. Mcnamara sold 15,000 shares of Chemed Corp. stock in a transaction that occurred on Friday, July 28th. The stock was sold at an average price of $201.16, for a total value of $3,017,400.00. Following the sale, the insider now directly owns 173,801 shares in the company, valued at approximately $34,961,809.16. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Patrick P. Grace sold 500 shares of Chemed Corp. stock in a transaction that occurred on Monday, October 2nd. The stock was sold at an average price of $201.48, for a total value of $100,740.00. Following the completion of the sale, the director now owns 4,515 shares in the company, valued at $909,682.20. The disclosure for this sale can be found here. Over the last quarter, insiders sold 16,500 shares of company stock worth $3,315,600. Corporate insiders own 5.32% of the company’s stock.
A number of research firms have issued reports on CHE. Zacks Investment Research cut Chemed Corp. from a “buy” rating to a “hold” rating in a report on Wednesday, September 13th. Royal Bank Of Canada restated a “hold” rating and set a $208.00 price target on shares of Chemed Corp. in a report on Wednesday, July 5th. BidaskClub cut Chemed Corp. from a “strong-buy” rating to a “buy” rating in a report on Thursday, June 22nd. Finally, Oppenheimer Holdings, Inc. increased their price target on Chemed Corp. from $200.00 to $220.00 and gave the stock an “outperform” rating in a report on Thursday, July 27th. Three equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. Chemed Corp. presently has an average rating of “Hold” and a consensus target price of $215.00.
Chemed Corp. (NYSE:CHE) opened at 204.78 on Friday. The company has a market capitalization of $3.27 billion, a PE ratio of 50.80 and a beta of 1.13. The firm’s 50 day moving average price is $196.38 and its 200-day moving average price is $197.78. Chemed Corp. has a 12-month low of $132.92 and a 12-month high of $216.01.
Chemed Corp. (NYSE:CHE) last issued its quarterly earnings data on Tuesday, July 25th. The company reported $2.15 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.89 by $0.26. The firm had revenue of $415.06 million for the quarter, compared to analyst estimates of $407.56 million. Chemed Corp. had a return on equity of 26.18% and a net margin of 4.16%. The business’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same period last year, the company earned $1.80 EPS. On average, equities analysts anticipate that Chemed Corp. will post $8.21 earnings per share for the current fiscal year.
Chemed Corp. Profile
Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.
Receive News & Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related companies with MarketBeat.com's FREE daily email newsletter.